Go to content
UR Home

Bullous Pemphigoid in Patients Receiving Immune Checkpoint Inhibitors and Psoriatic Patients — Focus on Clinical and Histopathological Variation

URN to cite this document:
DOI to cite this document:
Niebel, Dennis ; Wilsmann-Theis, Dagmar ; Bieber, Thomas ; Berneburg, Mark ; Wenzel, Joerg ; Braegelmann, Christine
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 05 Apr 2022 04:52


Background: The most common autoimmune blistering disease, bullous pemphigoid (BP), shows an increased prevalence in psoriatic patients and oncologic patients undergoing immune-checkpoint blockade (ICB). Even though the same autoantigens (BP180/BP230) are detectable, it remains obscure whether clinical or histopathological differences exist between these different groups of BP patients. In this ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons